We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 103.31 | 6 | 10:32:14 |
International stocks trading in New York closed lower on Thursday. The Bank of New York index of American depositary receipts fell 1.44%, to 155.14. The European index decreased 1.52%, to 153.23; the Asian index dropped 1.35%, to 149.28; the Latin American index fell 1.32%, to 299.7; and the emerging markets index declined 1.43%, to 293.89. Among the companies with shares that actively traded was SAP SE (SAP, SAP.XE).
SAP said that revenue from cloud applications rose rapidly in the second quarter, despite reporting a 23% drop in profit. But investors focused on revenue generated from the German software company's cloud-based products, which jumped 52% and management raised its forecast for full-year cloud revenue. Shares rose 1.3%, to $80.68.
Cemex SAB (CX, CEMEX.MX) shares fell after a report that housing starts in the southern U.S. fell 30% in June. The Mexico-based cement maker has a significant presence in the U.S., and particularly in the south. Shares declined 2.7% to $12.89.
Novartis AG (NVS, NOVN.VX) said strong sales in emerging markets fueled a 2% jump in second-quarter revenue, a performance that comes as the pharmaceutical giant readies for a sweeping overhaul that will narrow its focus. However the results missed expectations. Shares fell 1.7% to $88.53.
Write to Tess Stynes at tess.stynes@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions